Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children

Completed 90 enrolled The HIV Netherlands Australia Thailand Research Collaboration King Chulalongkorn Memorial Hospital · collab

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the immunogenicity and safety of 7 - valent pneumococcal conjugated vaccine in HIV - infected children, and assess the predictive factors for protective antibody responses after receiving the vaccine.

Timeline

Start: 2010-04
Primary completion: 2010-12
Completion: 2011-06

Publications

Results Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Prevnar 13	Vaccine	0.5 ml	Intramuscular

Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children

Summary

Timeline

Publications

Drugs

Indications